← NovoCure Ltd
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $82.9m |
$177.0m
+113.57%
|
$248.1m
+40.13%
|
$351.3m
+41.62%
|
$494.4m
+40.72%
|
$535.0m
+8.23%
|
$537.8m
+0.53%
|
$509.3m
-5.30%
|
$605.2m
+18.82%
|
$655.4m
+8.28%
|
$699.2m
+6.69%
|
|
| Cost of Goods and Services Sold | $39.9m |
$55.6m
+39.48%
|
$80.0m
+43.95%
|
$88.6m
+10.69%
|
$106.5m
+20.20%
|
$114.9m
+7.86%
|
$114.9m
-0.01%
|
$128.3m
+11.68%
|
$137.2m
+6.94%
|
$166.9m
+21.65%
|
$166.9m
+0.03%
|
|
| Gross Profit | $36.6m |
$121.4m
+231.69%
|
$168.0m
+38.38%
|
$262.7m
+56.36%
|
$387.9m
+47.64%
|
$420.2m
+8.32%
|
$423.0m
+0.67%
|
$381.1m
-9.91%
|
$468.0m
+22.83%
|
$488.5m
+4.37%
|
$532.3m
+8.97%
|
|
| Research and Development Expense | $41.5m | $38.1m | $50.6m | $79.0m | $132.0m | $201.3m | $206.1m | $223.1m | $209.6m | $224.5m | $224.7m | |
| Selling and Marketing Expense | $59.4m | $63.5m | $77.7m | $96.7m | $118.0m | $137.1m | $173.7m | $226.8m | $239.1m | $240.1m | $461.9m | |
| General and Administrative Expense | $51.0m | $59.1m | $73.5m | $87.9m | $107.4m | $126.1m | $132.8m | $164.1m | $189.8m | $177.7m | $214.7m | |
| Operating Lease, Expense | — | — | — | — | $6.0m | $7.3m | $7.1m | $8.2m | $9.2m | $12.0m | — | |
| Restructuring Costs | — | — | — | — | — | — | — | $6.2m | $2.0m | $0 | — | |
| Operating Expenses | $151.9m | $160.7m | $201.7m | $263.6m | $357.5m | $464.5m | $512.5m | $613.9m | $638.5m | $642.3m | $686.7m | |
| Operating Income (Loss) | ($115.3m) |
($39.3m)
+65.90%
|
($33.7m)
+14.38%
|
($914k)
+97.29%
|
$30.4m
+3426.15%
|
($44.3m)
-245.83%
|
($89.5m)
-101.93%
|
($232.9m)
-160.12%
|
($170.5m)
+26.78%
|
($153.8m)
+9.79%
|
($154.4m)
-0.39%
|
|
| Interest Expense | $7.3m | $11.7m | $16.9m | $14.6m | $18.1m | $8.8m | $8.1m | $4.9m | $11.7m | $22.2m | $17.0m | |
| Interest Expense, Debt | $5.9m | $10.3m | $13.5m | $13.7m | — | — | — | — | — | — | $17.0m | |
| Foreign Currency Transaction Gain (Loss), before Tax | — | — | — | $917k | $699k | ($3.2m) | $3.3m | ($161k) | $227k | ($1.3m) | — | |
| Interest Income (Expense), Nonoperating, Net | — | — | — | — | — | — | $7.7m | $41.1m | $39.3m | $17.6m | $12.9m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($81.0m) | ($77.7m) | ($114.9m) | ($87.9m) | ($15.3m) | $82.2m | ($269.6m) | ($281.7m) | ($205.3m) | ($205.4m) | ($152.7m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($121.5m) | ($48.5m) | ($45.9m) | ($8.8m) | $18.1m | ($52.1m) | ($81.8m) | ($191.7m) | ($131.2m) | ($136.2m) | ($152.7m) | |
| Current Income Tax Expense (Benefit) | $10.4m | $13.5m | $17.3m | ($1.7m) | ($1.7m) | $6.3m | $10.7m | $15.3m | $37.5m | ($23k) | ($4.1m) | |
| Income Tax Expense (Benefit) | $10.4m | $13.2m | $17.6m | ($1.6m) | ($1.7m) | $6.3m | $10.7m | $15.3m | $37.5m | ($23k) | ($4.1m) | |
| Net Income (Loss) Attributable to Parent | ($131.8m) |
($61.7m)
+53.23%
|
($63.6m)
-3.08%
|
($7.2m)
+88.62%
|
$19.8m
+373.97%
|
($58.4m)
-394.58%
|
($92.5m)
-58.58%
|
($207.0m)
-123.75%
|
($168.6m)
+18.55%
|
($136.2m)
+19.21%
|
($148.6m)
-9.06%
|
|
| Earnings Per Share, Basic | — | — | — | — | $0.20 | ($0.56) | ($0.88) | ($1.95) | ($1.56) | ($1.22) | ($1.30) | |
| Earnings Per Share, Diluted | — | — | — | — | $0.18 | ($0.56) | ($0.88) | ($1.95) | ($1.56) | ($1.22) | ($1.30) | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | 100.9m | 103.4m | 104.7m | 106.4m | 107.8m | 111.5m | 113.6m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | 108.9m | 103.4m | 104.7m | 106.4m | 107.8m | 111.5m | 113.6m | |
| Additional Financial Items | ||||||||||||
| Capitalized Computer Software, Amortization | $731k | $1.2m | $1.5m | $1.7m | $1.4m | $1.1m | $1.1m | $1.3m | $1.4m | $1.5m | — |